Annual Accounts Payable
$2.38 M
+$1.45 M+154.51%
December 31, 2023
Summary
- As of February 7, 2025, CNTX annual accounts payable is $2.38 million, with the most recent change of +$1.45 million (+154.51%) on December 31, 2023.
- During the last 3 years, CNTX annual accounts payable has fallen by -$324.90 thousand (-12.00%).
- CNTX annual accounts payable is now -12.00% below its all-time high of $2.71 million, reached on December 31, 2020.
Performance
CNTX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.03 M
+$417.20 K+68.23%
September 1, 2024
Summary
- As of February 7, 2025, CNTX quarterly accounts payable is $1.03 million, with the most recent change of +$417.20 thousand (+68.23%) on September 1, 2024.
- Over the past year, CNTX quarterly accounts payable has increased by +$417.20 thousand (+68.23%).
- CNTX quarterly accounts payable is now -66.64% below its all-time high of $3.08 million, reached on September 30, 2021.
Performance
CNTX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
CNTX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +154.5% | +68.2% |
| 3 y3 years | -12.0% | -13.6% |
| 5 y5 years | +15.2% | -13.6% |
CNTX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +154.5% | -56.8% | +126.2% |
| 5 y | 5-year | -12.0% | +154.5% | -66.6% | +126.2% |
| alltime | all time | -12.0% | +154.5% | -66.6% | +126.2% |
Context Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.03 M(+68.2%) |
| Jun 2024 | - | $611.50 K(-70.1%) |
| Mar 2024 | - | $2.05 M(-14.2%) |
| Dec 2023 | $2.38 M(+154.5%) | $2.38 M(+30.4%) |
| Sep 2023 | - | $1.83 M(+53.5%) |
| Jun 2023 | - | $1.19 M(-1.6%) |
| Mar 2023 | - | $1.21 M(+29.3%) |
| Dec 2022 | $936.30 K | $936.30 K(-37.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $1.50 M(+58.1%) |
| Jun 2022 | - | $945.50 K(+107.9%) |
| Mar 2022 | - | $454.80 K(-75.1%) |
| Dec 2021 | $1.83 M(-32.6%) | $1.83 M(-40.8%) |
| Sep 2021 | - | $3.08 M(+79.4%) |
| Jun 2021 | - | $1.72 M(-9.0%) |
| Mar 2021 | - | $1.89 M(-30.3%) |
| Dec 2020 | $2.71 M(+30.9%) | $2.71 M |
| Dec 2019 | $2.07 M | - |
FAQ
- What is Context Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Context Therapeutics?
- What is Context Therapeutics annual accounts payable year-on-year change?
- What is Context Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Context Therapeutics?
- What is Context Therapeutics quarterly accounts payable year-on-year change?
What is Context Therapeutics annual accounts payable?
The current annual accounts payable of CNTX is $2.38 M
What is the all time high annual accounts payable for Context Therapeutics?
Context Therapeutics all-time high annual accounts payable is $2.71 M
What is Context Therapeutics annual accounts payable year-on-year change?
Over the past year, CNTX annual accounts payable has changed by +$1.45 M (+154.51%)
What is Context Therapeutics quarterly accounts payable?
The current quarterly accounts payable of CNTX is $1.03 M
What is the all time high quarterly accounts payable for Context Therapeutics?
Context Therapeutics all-time high quarterly accounts payable is $3.08 M
What is Context Therapeutics quarterly accounts payable year-on-year change?
Over the past year, CNTX quarterly accounts payable has changed by +$417.20 K (+68.23%)